NCT04370457View on ClinicalTrials.gov

MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies

NAUnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

September 30, 2022

Conditions
Chronic Lymphocytic LeukemiaMyelodysplastic Syndromes
Interventions
OTHER

Administration of the MyPal ePRO system

Patients will be asked to complete self-report questionnaires at baseline, and every month for the first six months and at 12-month follow-up

Trial Locations (1)

20132

RECRUITING

IRCCS Ospedale San Raffaele, Milan

Sponsors
All Listed Sponsors
lead

Centre for Research and Technology Hellas

OTHER

NCT04370457 - MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies | Biotech Hunter | Biotech Hunter